Search results for "From Annals of Internal Medicine"
State caps on insulin costs for commercially insured didn't increase insulin use
Limits on out-of-pocket costs did lower patients' insulin expenses, but the effect was mostly limited to those with health savings accounts, a pre-post comparison among U.S. states found.
https://diabetes.acponline.org/archives/2024/04/12/6.htm
12 Apr 2024
Acute oxalate nephropathy in a patient with diabetes
A recent case report described a woman with long-standing diabetes who developed acute oxalate nephropathy during a hospitalization for diabetic ketoacidosis.
https://diabetes.acponline.org/archives/2024/02/09/8.htm
9 Feb 2024
Diabetes more common in low-income middle-aged people, rising among higher-income group
Between 1999 and 2020, rates of diabetes and obesity held steady in lower-income middle-aged adults in the U.S., while these risk factors rose among the higher-income middle-aged, from 7.8% to 14.9% and 33.0% to 44.0%, respectively.
https://diabetes.acponline.org/archives/2023/12/08/7.htm
8 Dec 2023
Finerenone works by quickly lowering albuminuria, analysis finds
Reductions in the urine albumin-to-creatinine ratio within four months were responsible for 84% of the treatment effect of finerenone on kidney outcomes and 37% of that on cardiovascular outcomes, according to an industry-funded four-year analysis of trials in patients with chronic kidney disease and type 2 diabetes.
https://diabetes.acponline.org/archives/2023/12/08/6.htm
8 Dec 2023
Annals On Call: Type 1 diabetes
Annals On Call is a podcast focusing on a clinically influential article published in Annals of Internal Medicine. A recent episode discussed the age at which U.S. adults with type 1 diabetes are being diagnosed.
https://diabetes.acponline.org/archives/2023/12/08/8.htm
8 Dec 2023
Case reports describe unusual occurrences in patients with diabetes
Recent case reports focused on linagliptin-induced pancreatitis and euglycemic diabetic ketoacidosis after cardiac surgery.
https://diabetes.acponline.org/archives/2023/10/13/8.htm
13 Oct 2023
Weekly insulin icodec superior to daily insulin analogues in latest manufacturer trial
Patients with type 2 diabetes who used weekly insulin icodec and a dosing app had greater reductions in HbA1c levels than similar patients randomized to start a daily insulin analogue with a traditional dosing strategy.
https://diabetes.acponline.org/archives/2023/10/13/6.htm
13 Oct 2023
Insulin costs, diabetes and testosterone
An Ideas and Opinions piece explained some of the factors behind insulin prices, and a meta-analysis looked at testosterone levels in men with diabetes.
https://diabetes.acponline.org/archives/2023/09/08/6.htm
8 Sep 2023
Crowdfunding campaigns often focus on overall cost of diabetes, rarely mention insulin
A quarter of fundraisers for patients with diabetes reported that the patient had insurance, and many mentioned noncovered costs such as lost wages, healthy food, and diabetic alert dogs.
https://diabetes.acponline.org/archives/2023/07/14/6.htm
14 Jul 2023
ACP Journal Club: SGLT-2 inhibitors reduce adverse renal and CV outcomes in patients with or without diabetes
The results of this meta-analysis of sodium-glucose cotransporter-2 (SGLT-2) inhibitors highlight the opportunity for internists, nephrologists, endocrinologists, and cardiologists to collaborate to expand use of the drug class, an ACP Journal Club commentary said.
https://diabetes.acponline.org/archives/2023/03/10/7.htm
10 Mar 2023